• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破骨细胞生成抑制因子/骨保护素减少了机械卸载诱导的骨质流失。

Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading.

作者信息

Ichinose Y, Tanaka H, Inoue M, Mochizuki S, Tsuda E, Seino Y

机构信息

Department of Pediatrics, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.

出版信息

Calcif Tissue Int. 2004 Oct;75(4):338-43. doi: 10.1007/s00223-004-0028-x. Epub 2004 Jul 30.

DOI:10.1007/s00223-004-0028-x
PMID:15549649
Abstract

Skeletal unloading resulting from space flight and prolonged immobilization causes bone loss. Such bone loss ostensibly results from a rapid increase in bone resorption and subsequent sustained reduction in bone formation, but this mechanism remains unclear. Osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) is a recently identified potent inhibitor of osteoclast formation. We studied effects of OPG administration on tail-suspended growing rats to explore the therapeutic potential of OPG in the treatment and prevention of bone loss during mechanical unloading, such as that which occurs during space flight. Treatment with OPG in tail suspension increased the total bone mineral content (BMC g) of the tibia and femur and the total bone mineral density (BMD g/cm2) of the tibia. Moreover, treatment with OPG prevented reduction not only of BMC and BMD, but also of bone strength occurring through femoral diaphysis. Treatment with OPG in tail-suspended rats improved BMC, BMD and bone strength to levels of normally loaded rats treated with vehicle. Treatment with OPG in normally loaded rats significantly decreased urinary excretion of deoxypyridinoline, but the effect of OPG in tail suspension was unclear. These results indicate that OPG may be useful in inhibiting bone loss-engendered mechanical unloading.

摘要

太空飞行和长期制动导致的骨骼失用会引起骨质流失。这种骨质流失表面上是由于骨吸收迅速增加以及随后骨形成持续减少所致,但这种机制仍不清楚。破骨细胞生成抑制因子/骨保护素(OCIF/OPG)是最近发现的一种有效的破骨细胞形成抑制剂。我们研究了给予OPG对尾部悬吊的生长中大鼠的影响,以探索OPG在治疗和预防机械性失用期间骨质流失(如太空飞行期间发生的骨质流失)方面的治疗潜力。在尾部悬吊模型中用OPG治疗可增加胫骨和股骨的总骨矿物质含量(BMC,克)以及胫骨的总骨矿物质密度(BMD,克/平方厘米)。此外,用OPG治疗不仅可防止BMC和BMD的降低,还可防止股骨骨干出现的骨强度降低。在尾部悬吊的大鼠中用OPG治疗可使BMC、BMD和骨强度提高到用赋形剂处理的正常负荷大鼠的水平。在正常负荷的大鼠中用OPG治疗可显著降低脱氧吡啶啉的尿排泄,但OPG在尾部悬吊模型中的作用尚不清楚。这些结果表明,OPG可能有助于抑制机械性失用引起的骨质流失。

相似文献

1
Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading.破骨细胞生成抑制因子/骨保护素减少了机械卸载诱导的骨质流失。
Calcif Tissue Int. 2004 Oct;75(4):338-43. doi: 10.1007/s00223-004-0028-x. Epub 2004 Jul 30.
2
Osteoprotegerin mitigates tail suspension-induced osteopenia.骨保护素减轻尾部悬吊诱导的骨质减少。
Bone. 2000 May;26(5):443-9. doi: 10.1016/S8756-3282(00)00256-8.
3
Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.骨保护素治疗会损害骨痂组织的重塑和表观材料特性,而不影响结构骨折强度。
Calcif Tissue Int. 2005 Apr;76(4):280-6. doi: 10.1007/s00223-004-0126-9. Epub 2005 Apr 11.
4
Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.2型糖尿病男性患者破骨细胞功能加速:破骨细胞生成抑制因子/骨保护素(OCIF/OPG)对骨密度降低的预防作用。
Diabetes Res Clin Pract. 2005 May;68(2):117-25. doi: 10.1016/j.diabres.2004.08.006.
5
Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats.
Calcif Tissue Int. 2005 Dec;77(6):376-85. doi: 10.1007/s00223-005-0123-7. Epub 2005 Dec 8.
6
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.破骨细胞生成抑制因子(OCIF)与骨保护素(OPG)的同一性:OPG/OCIF在体外抑制破骨细胞生成的机制
Endocrinology. 1998 Mar;139(3):1329-37. doi: 10.1210/endo.139.3.5837.
7
Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats.
J Bone Miner Metab. 2002;20(1):14-20. doi: 10.1007/s774-002-8441-x.
8
Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.
J Bone Miner Res. 2002 Jul;17(7):1256-63. doi: 10.1359/jbmr.2002.17.7.1256.
9
OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.骨保护素和甲状旁腺激素(1-34)对骨质疏松性卵巢切除大鼠的骨密度和力学强度具有相加作用。
Endocrinology. 2001 Oct;142(10):4295-304. doi: 10.1210/endo.142.10.8437.
10
A toxicity profile of osteoprotegerin in the cynomolgus monkey.食蟹猴中骨保护素的毒性概况。
Int J Toxicol. 2003 Sep-Oct;22(5):403-12. doi: 10.1177/109158180302200512.

引用本文的文献

1
Transcriptional responses of skeletal stem/progenitor cells to hindlimb unloading and recovery correlate with localized but not systemic multi-systems impacts.骨骼干/祖细胞对后肢卸载和恢复的转录反应与局部而非全身的多系统影响相关。
NPJ Microgravity. 2021 Nov 26;7(1):49. doi: 10.1038/s41526-021-00178-0.
2
Mechanical signaling for bone modeling and remodeling.骨骼塑形与重塑的机械信号传导
Crit Rev Eukaryot Gene Expr. 2009;19(4):319-38. doi: 10.1615/critreveukargeneexpr.v19.i4.50.
3
Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.
血浆骨保护素浓度升高与髋部骨强度指标相关。
J Clin Endocrinol Metab. 2008 May;93(5):1789-95. doi: 10.1210/jc.2007-2492. Epub 2008 Feb 26.
4
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.核因子κB受体活化因子配体与骨保护素在健康与疾病状态下对骨重塑的调节作用
Endocr Rev. 2008 Apr;29(2):155-92. doi: 10.1210/er.2007-0014. Epub 2007 Dec 5.
5
Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement.骨保护素的局部递送抑制正畸牙齿移动中机械介导的骨改建。
Bone. 2007 Sep;41(3):446-55. doi: 10.1016/j.bone.2007.04.194. Epub 2007 May 8.
6
The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys.RANKL抑制剂OPG-Fc可增加年轻性腺完整的食蟹猴的皮质骨和小梁骨量。
Osteoporos Int. 2007 Aug;18(8):1073-82. doi: 10.1007/s00198-007-0363-7. Epub 2007 Mar 24.